Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines

Anaphylaxis to vaccines is historically a rare event. The coronavirus disease 2019 pandemic drove the need for rapid vaccine production applying a novel antigen delivery system: messenger RNA vaccines packaged in lipid nanoparticles. Unexpectedly, public vaccine administration led to a small number...

Descripción completa

Detalles Bibliográficos
Autores principales: Risma, Kimberly A., Edwards, Kathryn M., Hummell, Donna S., Little, Frederic F., Norton, Allison E., Stallings, Amy, Wood, Robert A., Milner, Joshua D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Academy of Allergy, Asthma & Immunology 2021
Materias:
Covid-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056854/
https://www.ncbi.nlm.nih.gov/pubmed/33857566
http://dx.doi.org/10.1016/j.jaci.2021.04.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056854/
https://www.ncbi.nlm.nih.gov/pubmed/33857566
http://dx.doi.org/10.1016/j.jaci.2021.04.002

Ejemplares similares